Ratings iSpecimen Inc.

Equities

ISPC

US45032V1089

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
0.266 ^USD	-5.07%		-7.73%	-46.86%

Mar. 26	ISpecimen Inc. Announces the Board Changes	CI
Mar. 14	Transcript : ISpecimen Inc., 2023 Earnings Call, Mar 14, 2024

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
Low profitability weakens the company.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Sector: Software

	1st Jan change	Capi.	ESG Refinitiv
ISPECIMEN INC.	-46.86%	2.49M	-
MICROSOFT CORPORATION	+8.05%	3,020B	C+
SYNOPSYS INC.	+5.58%	82.93B	B
CADENCE DESIGN SYSTEMS, INC.	+3.69%	76.85B	B+
DASSAULT SYSTÈMES SE	-14.62%	53.04B	B+
PALANTIR TECHNOLOGIES INC.	+31.16%	50.15B	D+
ATLASSIAN CORPORATION	-24.56%	46.71B	B-
THE TRADE DESK, INC.	+17.75%	41.41B	D+
SEA LIMITED	+55.21%	36.1B	D+
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-10.24%	24.64B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes